| scholarly article | Q13442814 |
| P6179 | Dimensions Publication ID | 1018543232 |
| P356 | DOI | 10.1038/IJO.2016.81 |
| P932 | PMC publication ID | 5310821 |
| P698 | PubMed publication ID | 27133621 |
| P50 | author | Jessica Woo | Q76376140 |
| P2093 | author name string | M D DeBoer | |
| J A Morrison | |||
| M J Gurka | |||
| P2860 | cites work | Reduction in the Incidence of Type 2 Diabetes with Lifestyle Intervention or Metformin | Q22250892 |
| The Fourth Report on the Diagnosis, Evaluation, and Treatment of High Blood Pressure in Children and Adolescents | Q22305963 | ||
| The fat-derived hormone adiponectin reverses insulin resistance associated with both lipoatrophy and obesity | Q28506782 | ||
| Banting lecture 1988. Role of insulin resistance in human disease | Q29547283 | ||
| Mechanisms linking obesity to insulin resistance and type 2 diabetes | Q29614887 | ||
| Adiponectin and adiponectin receptors in insulin resistance, diabetes, and the metabolic syndrome | Q29619211 | ||
| Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement | Q29619465 | ||
| The severity of the metabolic syndrome increases over time within individuals, independent of baseline metabolic syndrome status and medication use: The Atherosclerosis Risk in Communities Study | Q30278617 | ||
| Severity of the metabolic syndrome as a predictor of type 2 diabetes between childhood and adulthood: the Princeton Lipid Research Cohort Study. | Q30278666 | ||
| Severity of Metabolic Syndrome as a Predictor of Cardiovascular Disease Between Childhood and Adulthood: The Princeton Lipid Research Cohort Study | Q30357151 | ||
| An examination of sex and racial/ethnic differences in the metabolic syndrome among adults: a confirmatory factor analysis and a resulting continuous severity score | Q30408379 | ||
| Obesity, systemic inflammation, and increased risk for cardiovascular disease and diabetes among adolescents: a need for screening tools to target interventions | Q30415102 | ||
| Racial/ethnic discrepancies in the metabolic syndrome begin in childhood and persist after adjustment for environmental factors | Q30422688 | ||
| A confirmatory factor analysis of the metabolic syndrome in adolescents: an examination of sex and racial/ethnic differences | Q30424086 | ||
| Ability among adolescents for the metabolic syndrome to predict elevations in factors associated with type 2 diabetes and cardiovascular disease: data from the national health and nutrition examination survey 1999-2006 | Q30431280 | ||
| Genetic architecture of lipid traits changes over time and differs by race: Princeton Lipid Follow-up Study | Q33825115 | ||
| Paradoxically high adiponectin in obese 16-year-old girls protects against appearance of the metabolic syndrome and its components seven years later | Q34496704 | ||
| Total and high-molecular-weight adiponectin and resistin in relation to the risk for type 2 diabetes in women | Q34819729 | ||
| Ethnic differences in triglyceride levels and high-density lipoprotein lead to underdiagnosis of the metabolic syndrome in black children and adults | Q35746178 | ||
| Prospective study of serum adiponectin and incident metabolic syndrome: the ARIRANG study | Q36868309 | ||
| Banting Lecture. From the triumvirate to the ominous octet: a new paradigm for the treatment of type 2 diabetes mellitus | Q37141727 | ||
| The perfect storm: obesity, adipocyte dysfunction, and metabolic consequences | Q37147602 | ||
| Adiponectin levels and risk of type 2 diabetes: a systematic review and meta-analysis | Q37543864 | ||
| Adiponectin and incident coronary heart disease and stroke. A systematic review and meta-analysis of prospective studies | Q38089799 | ||
| High adiponectin concentrations are associated with the metabolically healthy obese phenotype | Q38288536 | ||
| Hypoadiponectinemia in overweight children contributes to a negative metabolic risk profile 6 years later | Q39951081 | ||
| What is the best predictor of future type 2 diabetes? | Q40230327 | ||
| The metabolic syndrome and 11-year risk of incident cardiovascular disease in the atherosclerosis risk in communities study | Q42646355 | ||
| A comparison of the prevalence of the metabolic syndrome using two proposed definitions | Q44333376 | ||
| Plasma adiponectin levels and risk of myocardial infarction in men. | Q44843420 | ||
| National Cholesterol Education Program versus World Health Organization metabolic syndrome in relation to all-cause and cardiovascular mortality in the San Antonio Heart Study | Q45027914 | ||
| Impact of the metabolic syndrome on mortality from coronary heart disease, cardiovascular disease, and all causes in United States adults | Q45027927 | ||
| Metabolic syndrome in childhood predicts adult metabolic syndrome and type 2 diabetes mellitus 25 to 30 years later | Q46799989 | ||
| Measurement of the high-molecular weight form of adiponectin in plasma is useful for the prediction of insulin resistance and metabolic syndrome | Q47335890 | ||
| Insulin and risk of cardiovascular disease: a meta-analysis | Q49102279 | ||
| Adiponectin and Coronary Heart Disease | Q57416324 | ||
| Role of glucose and insulin resistance in development of type 2 diabetes mellitus: results of a 25-year follow-up study | Q67521964 | ||
| Relationships of measurements of body mass to plasma lipoproteins in schoolchildren and adults | Q71202491 | ||
| Serum concentrations of uric acid and the metabolic syndrome among US children and adolescents | Q80242235 | ||
| P433 | issue | 9 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | cardiovascular disease | Q389735 |
| metabolic syndrome | Q657193 | ||
| type 2 diabetes | Q3025883 | ||
| P304 | page(s) | 1353-1359 | |
| P577 | publication date | 2016-05-02 | |
| P1433 | published in | International Journal of Obesity | Q6051519 |
| P1476 | title | Inter-relationships between the severity of metabolic syndrome, insulin and adiponectin and their relationship to future type 2 diabetes and cardiovascular disease | |
| P478 | volume | 40 |
| Q92432411 | ADIPONECTIN AS A POTENTIAL BIOMARKER OF LOW BONE MINERAL DENSITY IN POSTMENOPAUSAL WOMEN WITH METABOLIC SYNDROME |
| Q58129747 | Assessing Baseline and Temporal Changes in Cardiometabolic Risk Using Metabolic Syndrome Severity and Common Risk Scores |
| Q92421225 | Assessing and Managing the Metabolic Syndrome in Children and Adolescents |
| Q55362962 | Assessing the added predictive ability of a metabolic syndrome severity score in predicting incident cardiovascular disease and type 2 diabetes: the Atherosclerosis Risk in Communities Study and Jackson Heart Study. |
| Q30253051 | Clinical utility of metabolic syndrome severity scores: considerations for practitioners |
| Q30252986 | Correlation of metabolic syndrome severity with cardiovascular health markers in adolescents |
| Q90358353 | Dietary fermented products using koji mold and sweet potato-shochu distillery by-product promotes hepatic and serum cholesterol levels and modulates gut microbiota in mice fed a high-cholesterol diet |
| Q91606940 | Fetuin-a to adiponectin ratio is a sensitive indicator for evaluating metabolic syndrome in the elderly |
| Q90267333 | Geographical variation in the prevalence of obesity and metabolic syndrome among US adolescents |
| Q52651258 | Geographical variation in the prevalence of obesity, metabolic syndrome, and diabetes among US adults. |
| Q30252634 | Heritability of the Severity of the Metabolic Syndrome in Whites and Blacks in 3 Large Cohorts |
| Q30252718 | Independent associations between a metabolic syndrome severity score and future diabetes by sex and race: the Atherosclerosis Risk In Communities Study and Jackson Heart Study |
| Q51244328 | Longitudinal Associations of Metabolic Syndrome Severity Between Childhood and Young Adulthood: The Bogalusa Heart Study. |
| Q56394611 | Metabolic Syndrome Severity and Risk of CKD and Worsened GFR: The Jackson Heart Study |
| Q30276601 | Metabolic risk factors in nondiabetic adolescents with glomerular hyperfiltration |
| Q56345044 | Metabolic syndrome severity and lifestyle factors among adolescents |
| Q47722871 | Metabolic syndrome severity is significantly associated with future coronary heart disease in Type 2 diabetes |
| Q30276204 | Progression of Metabolic Syndrome Severity During the Menopausal Transition |
| Q65001846 | The association of depression and posttraumatic stress disorder with the metabolic syndrome in a multi-ethnic cohort: the HELIUS study. |
| Q50057557 | Use of BMI as marker of adiposity in a metabolic syndrome severity score: derivation and validation in predicting long-term disease outcomes |
| Q57054483 | Use of a Metabolic Syndrome Severity Score to Track Risk During Treatment of Prediabetes: An Analysis of the Diabetes Prevention Program |
Search more.